- Home
- ORIC vs GPAT Comparison
ORIC vs GPAT Comparison
Compare ORIC & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- GPAT
- Stock Information
- Founded
- ORIC 2014
- GPAT 2020
- Country
- ORIC United States
- GPAT United States
- Employees
- ORIC N/A
- GPAT N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- GPAT
- Sector
- ORIC Health Care
- GPAT
- Exchange
- ORIC Nasdaq
- GPAT NYSE
- Market Cap
- ORIC 362.9M
- GPAT 365.5M
- IPO Year
- ORIC 2020
- GPAT 2024
- Fundamental
- Price
- ORIC $5.08
- GPAT $10.45
- Analyst Decision
- ORIC Strong Buy
- GPAT
- Analyst Count
- ORIC 8
- GPAT 0
- Target Price
- ORIC $18.83
- GPAT N/A
- AVG Volume (30 Days)
- ORIC 630.2K
- GPAT 198.3K
- Earning Date
- ORIC 05-05-2025
- GPAT 01-01-0001
- Dividend Yield
- ORIC N/A
- GPAT N/A
- EPS Growth
- ORIC N/A
- GPAT N/A
- EPS
- ORIC N/A
- GPAT 0.34
- Revenue
- ORIC N/A
- GPAT N/A
- Revenue This Year
- ORIC N/A
- GPAT N/A
- Revenue Next Year
- ORIC N/A
- GPAT N/A
- P/E Ratio
- ORIC N/A
- GPAT $30.28
- Revenue Growth
- ORIC N/A
- GPAT N/A
- 52 Week Low
- ORIC $3.90
- GPAT $9.98
- 52 Week High
- ORIC $14.67
- GPAT $10.45
- Technical
- Relative Strength Index (RSI)
- ORIC 44.71
- GPAT N/A
- Support Level
- ORIC $4.52
- GPAT N/A
- Resistance Level
- ORIC $5.83
- GPAT N/A
- Average True Range (ATR)
- ORIC 0.52
- GPAT 0.00
- MACD
- ORIC 0.07
- GPAT 0.00
- Stochastic Oscillator
- ORIC 40.58
- GPAT 0.00
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.